Evidence map›Paper›PMID 39396761›Full record

ArticleThe Journal of nutrition2024

Associations between SARS-CoV-2 Infection or COVID-19 Vaccination and Human Milk Composition: A Multi-Omics Approach.

Sneha P Couvillion, Ernesto S Nakayasu, Bobbie-Jo M Webb-Robertson, Isabella H Yang, Josie G Eder, Carrie D Nicora, Lisa M Bramer, Yuqian Gao, Alisa Fox, Claire DeCarlo and 8 more

Abstract read
In one paragraph

Article in The Journal of nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Sneha P CouvillionBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, United States.
Ernesto S NakayasuBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, United States.
Bobbie-Jo M Webb-RobertsonBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, United States.
Isabella H YangBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, United States.
Josie G EderBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, United States.
Carrie D NicoraBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, United States.
Lisa M BramerBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, United States.
Yuqian GaoBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, United States.
Alisa FoxDepartment of Medicine, Division of Infectious Diseases, Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Claire DeCarloDepartment of Medicine, Division of Infectious Diseases, Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Xiaoqi YangDepartment of Medicine, Division of Infectious Diseases, Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Mowei ZhouEnvironmental and Molecular Sciences Division, Pacific Northwest National Laboratory, Richland, WA, United States.
Ryan M PaceMargaret Ritchie School of Family and Consumer Sciences, University of Idaho, Moscow, Idaho, United States; College of Nursing, University of South Florida, Tampa, FL, USA.
Janet E WilliamsDepartment of Animal, Veterinary and Food Sciences, University of Idaho, Moscow, Idaho, United States.
Mark A McGuireDepartment of Animal, Veterinary and Food Sciences, University of Idaho, Moscow, Idaho, United States.
Michelle K McGuireMargaret Ritchie School of Family and Consumer Sciences, University of Idaho, Moscow, Idaho, United States.
Thomas O MetzBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, United States.
Rebecca Lr PowellDepartment of Medicine, Division of Infectious Diseases, Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY, United States. Electronic address: rebecca.powell@mssm.edu.

Funding

Research Project - RPL LaneP20GM152304 · NIGMS · UNIVERSITY OF IDAHO · PI Ginny Lane · 2024 to 2026
$8.9M
Mammary and milk microbiomes and metabolomes - Understanding early variation and impacts on risk for mammary inflammation and mastitisR01HD092297 · NICHD · UNIVERSITY OF IDAHO · PI MCGUIRE, MICHELLE KAY · 2018 to 2022
$2.4M
Gates Foundation INV-016943NICHD NIH HHS R01 HD092297NIGMS NIH HHS P20 GM152304
6 · The paper itself

Abstract

backgroundThe risk of contracting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) via human milk-feeding is virtually nonexistent. Adverse effects of coronavirus disease 2019 (COVID-19) vaccination for lactating individuals are not different from the general population, and no evidence has been found that their infants exhibit adverse effects. Yet, there remains substantial hesitation among this population globally regarding the safety of these vaccines.

objectivesHerein, we aimed to determine if compositional changes in milk occur following SARS-CoV-2 infection or COVID-19 vaccination, including any evidence of vaccine components.

methodsAn extensive multiomics approach was taken using a subset of milk samples obtained as part of our broad studies examining the effects on milk of SARS-CoV-2 infection and COVID-19 vaccination.

resultsWe found that compared with unvaccinated individuals, SARS-CoV-2 infection was associated with significant compositional differences in 67 proteins, 385 lipids, and 13 metabolites. In contrast, COVID-19 vaccination was not associated with any changes in lipids or metabolites, although it was associated with changes in 13 or fewer proteins. Compositional changes in milk differed by vaccine. Changes following vaccination were greatest after 1-6 h for the mRNA-based Moderna vaccine (8 changed proteins), 3 d for the mRNA-based Pfizer (4 changed proteins), and adenovirus-based Johnson and Johnson (13 changed proteins) vaccines. Proteins that changed after both natural infection and Johnson and Johnson vaccine were associated mainly with systemic inflammatory responses. In addition, no vaccine components were detected in any milk sample.

conclusionsTogether, our data provide evidence of only minimal changes in milk composition because of COVID-19 vaccination, with much greater changes after natural SARS-CoV-2 infection.

Indexed as

COVID-19COVID-19 VaccinesMilk, HumanSARS-CoV-2AdultFemaleHumansLipidsMultiomicsVaccinationCOVID-19 VaccinesLipidsbreastmilkCOVID-19human milkmaternal multiomicsSARS-CoV-2vaccination

Identifiers

PMID39396761
PMCPMC11662230

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.